101 related articles for article (PubMed ID: 9366990)
1. New trends in maintenance immunosuppression.
Isoniemi H
Ann Chir Gynaecol; 1997; 86(2):164-70. PubMed ID: 9366990
[TBL] [Abstract][Full Text] [Related]
2. Evolving trends in induction therapy.
Arias M; Campistol JM; Vincenti F
Transplant Rev (Orlando); 2009 Apr; 23(2):94-102. PubMed ID: 19298940
[TBL] [Abstract][Full Text] [Related]
3. Evolving immunosuppressive regimens for lung transplant recipients.
Meyer NJ; Bhorade SM
Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
[TBL] [Abstract][Full Text] [Related]
4. Renal transplantation, past, present and future.
Ponticelli C; Tarantino A; Vegeto A
J Nephrol; 1999; 12 Suppl 2():S105-10. PubMed ID: 10688409
[TBL] [Abstract][Full Text] [Related]
5. Cardiac transplantation: the changing faces of immunosuppression.
Metzger JT; Hoffman LA
Heart Lung; 1988 Jul; 17(4):414-25. PubMed ID: 3292466
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive agents in organ transplantation].
Bergan S; Albrechtsen D; Bentdal O
Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3615-20. PubMed ID: 10563181
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.
Taylor AL; Watson CJ; Bradley JA
Crit Rev Oncol Hematol; 2005 Oct; 56(1):23-46. PubMed ID: 16039869
[TBL] [Abstract][Full Text] [Related]
8. New directions for induction immunosuppression strategy in solid organ transplantation.
Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA
Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743
[TBL] [Abstract][Full Text] [Related]
9. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
10. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
Cantarovich D
J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
[TBL] [Abstract][Full Text] [Related]
11. Prospects for personalized immunosuppression: pharmacologic tools--a review.
Del Tacca M
Transplant Proc; 2004 Apr; 36(3):687-9. PubMed ID: 15110631
[TBL] [Abstract][Full Text] [Related]
12. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
[TBL] [Abstract][Full Text] [Related]
13. [Controversies about the use of calcineurin inhibitors in pediatric patients].
Dello Strologo L
G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
[TBL] [Abstract][Full Text] [Related]
14. [Advances in immunossuppression in liver transplantation].
Olivera-Martínez MA
Rev Invest Clin; 2005; 57(2):237-43. PubMed ID: 16524064
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the Multinational Observational Study (MOST).
Kliem V; Fritsche L; Haller H; Suwelack B; Abendroth D; Fornara P; Pietruck F; Frei U; Donauer J; Lison AE; Michel U; Ulbricht B;
Transplant Proc; 2005 Apr; 37(3):1597-600. PubMed ID: 15866683
[TBL] [Abstract][Full Text] [Related]
16. Optimum maintenance trough levels of cyclosporine in heart transplant recipients given corticosteroid-free regimen.
Nohria A; Ehtisham J; Ramahi TM
J Heart Lung Transplant; 1998 Sep; 17(9):849-53. PubMed ID: 9773855
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
[TBL] [Abstract][Full Text] [Related]
18. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
19. New paradigms in immunosuppression.
Huizinga R; Voyer T
CANNT J; 2003; 13(3):66-8. PubMed ID: 14596200
[TBL] [Abstract][Full Text] [Related]
20. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
Câmara NO; Dias MF; Pacheco-Silva A
Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
